SMTL ID : 7bgc.1

human butyrylcholinesterase in complex with a tacrine-methylanacardate hybrid inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

monomer

Ligands

1 x NAG- NAG- MAN- MAN- FUC: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-MAN-MAN-FUC.1: 2 residues within 4Å: Chain A: R.14, N.57 No protein-ligand interaction detected (PLIP)

1 x GAL- SIA: N-acetyl-alpha-neuraminic acid-(2-3)-beta-D-galactopyranose(Non-covalent)

GAL-SIA.2: 3 residues within 4Å: Chain A: K.60, N.63, D.87 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:N.63, A:N.63 Salt bridges: A:K.60

2 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-FUC.3: 5 residues within 4Å: Chain A: N.241, N.245, L.249, F.278, P.281 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:L.249 Hydrogen bonds: A:N.245 NAG-NAG-FUC.4: 4 residues within 4Å: Chain A: G.336, S.338, N.341, I.344 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:G.336

1 x TKN: methyl 2-methoxy-6-[(~{E})-8-(1,2,3,4-tetrahydroacridin-9-ylamino)oct-6-enyl]benzoate(Non-covalent)

TKN.5: 19 residues within 4Å: Chain A: D.70, W.82, G.115, G.116, G.117, E.197, S.198, W.231, L.286, S.287, V.288, A.328, F.329, Y.332, F.398, W.430, M.437, H.438, Y.440 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:D.70, A:V.288, A:A.328, A:W.430, A:Y.440 Water bridges: A:W.82 pi-Stacking: A:W.82, A:W.82, A:W.82

3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.6: 2 residues within 4Å: Chain A: N.106, N.188 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:N.188 NAG.7: 2 residues within 4Å: Chain A: N.256, E.259 No protein-ligand interaction detected (PLIP) NAG.8: 2 residues within 4Å: Chain A: R.465, N.485 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:R.465 Hydrogen bonds: A:N.485

1 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)

MES.9: 5 residues within 4Å: Chain A: K.323, Y.420, L.514, R.515, Q.518 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:R.515, A:Q.518 Water bridges: A:Q.517 Salt bridges: A:R.515

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.10: 5 residues within 4Å: Chain A: L.18, Y.61, W.98, D.129, K.131 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:Y.61, A:W.98, A:K.131 Water bridges: A:Y.61, A:D.129

3 x CL: CHLORIDE ION(Non-functional Binders)

CL.11: 2 residues within 4Å: Chain A: R.347, Q.351 Ligand excluded by PLIP CL.12: 1 residues within 4Å: Chain A: Y.385 Ligand excluded by PLIP CL.13: 0 residues within 4Å: (No contacts) Ligand excluded by PLIP

3 x SO4: SULFATE ION(Non-functional Binders)

SO4.14: 4 residues within 4Å: Chain A: R.242, L.286, S.287, V.288 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:L.286, A:V.288 Salt bridges: A:R.242 SO4.15: 4 residues within 4Å: Chain A: R.470, S.487, T.488, T.508 7 PLIP interactions: 7 interactions with chain A Hydrogen bonds: A:R.470, A:S.487, A:T.488, A:T.488, A:T.508, A:T.508, A:T.508 SO4.16: 4 residues within 4Å: Chain A: Q.316, G.413, N.414, N.415 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:Q.316, A:N.414, A:N.415

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Rossi, M. et al., Sustainable Drug Discovery of Multi-Target-Directed Ligands for Alzheimer's Disease. J.Med.Chem. (2021)

Release Date

2021-04-28

Peptides

Cholinesterase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cholinesterase

Related Entries With Identical Sequence